How Gottlieb is straddling industry, public health interests as FDA head

Scott Gottlieb, MD, stepped into his role as FDA commissioner amid much scrutiny over his deep ties to the drug and device industry. More than nine months into his leadership position, Dr. Gottlieb has managed an impressive feat for an FDA head — protecting America’s public health without losing support from industry stakeholders, according to The New York Times.

Advertisement

Dr. Gottlieb is leading the agency through a collaborative management style, promoting longtime FDA veterans and filling other positions with former industry members. Agency employees told The Times he is an energetic and intense leader who holds “town hall-style meetings before making decisions,” according to the report.

Part of Dr. Gottlieb’s success also comes from his balanced efforts to protect public health, while also proposing rewards for drug and device companies.

“He’s being thoughtful; he’s being deliberative,” William Hubbard, a 30-year FDA veteran, now retired, told The Times. “He seems to be putting aside some of his more extreme rhetoric from when he was outside, and working through the issues with a public-health orientation.”

More articles on supply chain:
FDA OKs Novartis’ generic version of Teva’s MS drug: 3 things to know
Walgreens is reportedly in talks to purchase AmerisourceBergen: 7 things to know
Philips recalls HeartStart MRx Defibrillator: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.